Article
Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma.
Frontiers in immunology - 1 Jan 2020
Iyoda Takuya, Fujita Motomichi, Fukai Fumio
Abstract excerpt
Tenascin (TN)-C is highly expressed specifically in the lesions of inflammation-related diseases, including tumors. The expression level of TN-C in tumors and the tumor stroma is positively correlated with poor prognosis. However, no drugs targeting TN-C are currently clinically available, partly because the role of TN-C in tumor progression remains controversial. TN-C harbors an alternative splicing site in its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
